The NACE Journal Club with Dr. Neil Skolnik, #5 episode artwork

EPISODE · Nov 10, 2023 · 22 MIN

The NACE Journal Club with Dr. Neil Skolnik, #5

from The NACE Clinical Highlights Show · host NACE

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial –The New England Journal of MedicineGuest:Marrisa Norden, DOResidentFamily Medicine ResidencyJefferson Health-Abington, Abington, PA2. Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation ARandomized Clinical Trial - JAMAGuest:Richard Potter, MDResidentFamily Medicine ResidencyJefferson Health-Abington, Abington, PA3. Sedentary Behavior and Incident Dementia Among Older Adults - JAMAGuest: Michael Devano, DOResidentFamily Medicine ResidencyJefferson Health-Abington, Abington, PAMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Episode metadata supplied by the publisher feed · Published Nov 10, 2023

Embed this episode

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications: 1. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial – The New England Journal of Medicine Guest: Marrisa Norden, DO Resident Family Medicine Residency Jefferson Health-Abington, Abington, PA 2. Muvalaplin, an Oral Small Molec...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

The NACE Journal Club with Dr. Neil Skolnik, #5

0:00 22:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The NACE Clinical Highlights Show?

This episode is 22 minutes long.

When was this The NACE Clinical Highlights Show episode published?

This episode was published on November 10, 2023.

Can I download this The NACE Clinical Highlights Show episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!